Breaking News

You are here » Indian-Commodity  :  Top News  :  Strides Shasun's arm receives acceptance from USFDA for two key ANDAs

22-Aug2018

Strides Shasun's arm receives acceptance from USFDA for two key ANDAs

Strides Shasun's step-down wholly owned subsidiary, Strides Pharma Global, Singapore has received Abbreviated New Drug Application (ANDA) “acceptable for filing” correspondence from the United States Food and Drug Administration (USFDA) for two key ANDAs that met the prioritization factors as a potential First Generic with a 10- month GDUFA II review goal date. As per IQVIA MAT data, the US market for these products cumulatively is $550 million.

The USFDA also granted Strides' request to designate the drug product under these ANDAs as a Competitive Generic Therapy (CGT). If the company is the first approved applicant with such competitive generic therapies, these products could be eligible for a potential 180-day CGT exclusivity, which functions in a similar manner to the Patent Challenge exclusivity for ANDAs.

Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company manufactures range of soft gel in category of nutraceuticals, Rx, specialty OTCs and immunosuppressants. 



Related News

View all news

Gold futures end lower on Tuesday

Gold futures ended lower on Tuesday on the back of a strong dollar against some major basket of currencies. Besides, slightly easing worries about US-China trade disputes after the two countries resumed......

Copper futures end higher on Tuesday

Copper futures ended higher on Tuesday as worries about growth in top consumer China receded after a report that the country's chief trade negotiator could visit the United States before a meeting between......

Physical Rubber prices extend weakness on Tuesday

Physical Rubber prices extended weakness on Tuesday amidst extremely dull volumes in the market. The market managed to sustain at the prevailing levels on enquiries from the tyre sector.Spot prices for......

Top News

View all news

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Govt in favour of alignment of capital adequacy norms with Basel III norms

Instead of present stricter guidelines which restrict the lending capacity of lenders, the government is of the view that the Reserve Bank of India (RBI) should resort to Basel III norms for capital adequacy......

Infosys, Ashok Leyland and Reliance Infrastructure to see some action today

Infosys will open its next Technology and Innovation Hub in the State of Texas and hire 500 American workers in the state by 2020. The Hub will be located in Richardson, Texas and have a special focus......